Amit Kumar Srivastava
VIDWAN ID: 256777

Dr Amit Kumar Srivastava

Male
Scientist | Cancer Biology and Inflammatory Disorder
CSIR-Indian Institute of Chemical Biology
West Bengal
Expertise: Biology
43 Publications
0 Projects
785 Scopus Citations
752 CrossRef
8 Years 4 Months Total Experience
Publications
43 Total
Articles
39
Chapters
4
Activity

No publication activity to display.

Scopus Scopus
785 Citations
14 h-index
CrossRef CrossRef
752 Citations
14 h-index
Google Scholar Google Scholar

Loading Scholar statistics...

Professional Recognition

No Data Found

There is currently nothing to display here.

Community & Membership

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

Personal Details

No Information Available

No information is available at this time.

Scientist
May 2018 – Present
CSIR-Indian Institute of Chemical Biology | Cancer Biology and Inflammatory Disorder
Biological Sciences
Biology

Related Profiles

Scholarly Work

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

Scholarly Publications

DNA polymerase eta: A potential pharmacological target for cancer therapy

Review
JOURNAL OF CELLULAR PHYSIOLOGY. Year: 2021. Volume: 236 , Issue: 6 , Pages: 4106-4120 .
Authors: Priyanka Saha; Tanima Mandal; Anupam D. Talukdar; Deepak Kumar; Sanjay Kumar; Prem P. Tripathi; Qi‐En Wang; Amit K. Srivastava

A substrate for a cell free in vitro assay system to screen drugs targeting trypsin like protease-based cleavage of SARS-CoV-2 spike glycoprotein and viral entry

Open Access
Journal Article
JOURNAL OF MEDICAL VIROLOGY. Year: 2023. Volume: 95 , Issue: 5 .
Authors: Feroza Begum; Amit K. Srivastava; Prem Prakash Tripathi; Upasana Ray

Chemokines driven ovarian cancer progression, metastasis and chemoresistance: Potential pharmacological targets for cancer therapy

Review
Seminars in Cancer Biology. Year: 2022. Volume: 86 , Pages: 568-579 .
Authors: Subhankar Bose; Priyanka Saha; Bilash Chatterjee; Amit Kumar Srivastava

KLF8 is activated by TGF-β1 via Smad2 and contributes to ovarian cancer progression

Journal Article
JOURNAL OF CELLULAR BIOCHEMISTRY. Year: 2022. Volume: 123 , Issue: 5 , Pages: 921-934 .
Authors: Aparna Cherukunnath; Ravichandra S. Davargaon; Rahail Ashraf; Urja Kamdar; Amit K. Srivastava; Prem P. Tripathi; Nabanita Chatterjee; Sanjay Kumar

Editorial: Inflammation and Myeloid Cells in Cancer Progression and Metastasis

Open Access
Editorial
Authors: Sanjay Mishra; Dinesh K. Ahirwar; Amit Kumar Srivastava; Prem Prakash Tripathi; Ramesh K. Ganju

Clinical potential of nanotechnlogy as smart therapeutics: A step toward targeted drug delivery

Book Chapter
Year: 2022. Pages: 133-154 .
Authors: Priyanka Saha; Subhankar Bose; Md Noushad Javed; Amit K. Srivastava

Purification and identification of anticancer organosulfides from Ferula assa-foetida gum: integrative analysis employing GC/GC-MS/RP-HPLC/NMR

Journal Article
Natural Product Research. Year: 2022. Volume: 36 , Issue: 11 , Pages: 2869-2874 .
Authors: Priyanka Yatham; Devendra Shukla; Amit K. Srivastava; V.S. Pragadheesh; Deepak Kumar

Complexity of Tumor Microenvironment: Therapeutic Role of Curcumin and Its Metabolites

Review
Nutrition and Cancer. Year: 2022. Volume: 75 , Issue: 1 , Pages: 1-13 .
Authors: Sahdeo Prasad; Priyanka Saha; Bilash Chatterjee; Anis Ahmad Chaudhary; Rajiv Lall; Amit K Srivastava
Showing 1 to 8 of 43 publications